XTNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Xtant Medical Holdings Inc (XTNT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock's technical indicators are bearish, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. While revenue growth is promising, the sharp decline in net income and EPS raises concerns about the company's profitability. Given the lack of recent news, analyst ratings, or influential trading data, it is better to hold off on investing in this stock until clearer positive signals emerge.
The technical indicators for XTNT are bearish. The MACD is negatively expanding below zero, the RSI is neutral at 36.749, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 0.559, with resistance at 0.617 and 0.674.
Revenue increased by 19.04% YoY in Q3 2025, and gross margin improved to 66.13%, up 13.29% YoY.
Net income dropped by -126.04% YoY, and EPS declined by -125.00% YoY, indicating significant profitability issues. There is no recent news or significant trading trends from hedge funds, insiders, or Congress.
In Q3 2025, revenue increased to $33,255,000 (up 19.04% YoY), but net income dropped to $1,308,000 (-126.04% YoY), and EPS fell to 0.01 (-125.00% YoY). Gross margin improved to 66.13% (up 13.29% YoY).
No recent analyst ratings or price target changes are available.
